Brief: Knight Therapeutics acquires minor stake in Pediapharm
July 15 (Reuters) - GUD.TO
* Knight acquires minor stake in Pediapharm
* Says has acquired 11.5 million shares of Pediapharm Inc
* Knight Therapeutics says shares in exchange for 221,126
shares of Knight and 221,126 four year warrants of Knight, with
exercise price of $10.00
* Says acquired shares for investment purposes
Source text for Eikon: ID:nCCN3yZdy7
Further company coverage: GUD.TO
(Bengaluru Newsroom; +1 646 223 8780)
Recent news on Medexus Pharmaceuticals
See all newsCanada's Medexus Q4 revenue misses analyst expectations, net loss widens
Brief: Medexus Pharmaceuticals Q4 Revenue USD 24.652 Million Vs. IBES Estimate USD 25.6 Million
Canada Research Roundup: CAE, Medexus Pharmaceuticals, TCP Energy
Medexus Pharma Q2 revenue misses estimates
Brief: Medexus Pharmaceuticals Q2 Revenue USD 24.741 Million Vs. IBES Estimate USD 25.6 Million